» Articles » PMID: 17431504

CaMKII Regulates Retinoic Acid Receptor Transcriptional Activity and the Differentiation of Myeloid Leukemia Cells

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2007 Apr 14
PMID 17431504
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoic acid receptors (RARs) are members of the nuclear hormone receptor family and regulate the proliferation and differentiation of multiple different cell types, including promyelocytic leukemia cells. Here we describe a biochemical/functional interaction between the Ca(2+)/calmodulin-dependent protein kinases (CaMKs) and RARs that modulates the differentiation of myeloid leukemia cells. We observe that CaMKIIgamma is the CaMK that is predominantly expressed in myeloid cells. CaMKII inhibits RAR transcriptional activity, and this enzyme directly interacts with RAR through a CaMKII LxxLL binding motif. CaMKIIgamma phosphorylates RARalpha both in vitro and in vivo, and this phosphorylation inhibits RARalpha activity by enhancing its interaction with transcriptional corepressors. In myeloid cell lines, CaMKIIgamma localizes to RAR target sites within myeloid gene promoters but dissociates from the promoter upon retinoic acid-induced myeloid cell differentiation. KN62, a pharmacological inhibitor of the CaMKs, enhances the terminal differentiation of myeloid leukemia cell lines, and this is associated with a reduction in activated (autophosphorylated) CaMKII in the terminally differentiating cells. These observations reveal a significant cross-talk between Ca(2+) and retinoic acid signaling pathways that regulates the differentiation of myeloid leukemia cells, and they suggest that CaMKIIgamma may provide a new therapeutic target for the treatment of certain human myeloid leukemias.

Citing Articles

miR-1 as a Key Epigenetic Regulator in Early Differentiation of Cardiac Sinoatrial Region.

Garcia-Padilla C, Lozano-Velasco E, Garcia-Lopez V, Aranega A, Franco D, Garcia-Martinez V Int J Mol Sci. 2024; 25(12).

PMID: 38928314 PMC: 11204236. DOI: 10.3390/ijms25126608.


Unveiling the role of CaMKII in retinal degeneration: from biological mechanism to therapeutic strategies.

Sun Y, Hao M, Wu H, Zhang C, Wei D, Li S Cell Biosci. 2024; 14(1):59.

PMID: 38725013 PMC: 11084033. DOI: 10.1186/s13578-024-01236-2.


Constitutively active CaMKII Drives B lineage acute lymphoblastic leukemia/lymphoma in tp53 mutant zebrafish.

Rothschild S, Lai G, Tombes R, Clements W PLoS Genet. 2023; 19(12):e1011102.

PMID: 38117861 PMC: 10766190. DOI: 10.1371/journal.pgen.1011102.


Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells.

Han J, Jung H Molecules. 2022; 27(22).

PMID: 36432068 PMC: 9699626. DOI: 10.3390/molecules27227968.


Put in a "Call" to Acute Myeloid Leukemia.

Lewuillon C, Laguillaumie M, Quesnel B, Idziorek T, Touil Y, Lemonnier L Cells. 2022; 11(3).

PMID: 35159351 PMC: 8834247. DOI: 10.3390/cells11030543.


References
1.
Perissi V, Staszewski L, McInerney E, Kurokawa R, Krones A, Rose D . Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 2000; 13(24):3198-208. PMC: 317209. DOI: 10.1101/gad.13.24.3198. View

2.
Means A . Expression of a constitutive form of calcium/calmodulin dependent protein kinase II leads to arrest of the cell cycle in G2. EMBO J. 1992; 11(2):507-17. PMC: 556481. DOI: 10.1002/j.1460-2075.1992.tb05081.x. View

3.
Means A . Regulatory cascades involving calmodulin-dependent protein kinases. Mol Endocrinol. 2000; 14(1):4-13. DOI: 10.1210/mend.14.1.0414. View

4.
Glass C, Rosenfeld M . The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000; 14(2):121-41. View

5.
Rachez C, Gamble M, Chang C, Atkins G, Lazar M, Freedman L . The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol Cell Biol. 2000; 20(8):2718-26. PMC: 85487. DOI: 10.1128/MCB.20.8.2718-2726.2000. View